Evidence map›Paper›PMID 20581311›Full record

ArticleBlood2010

STAT3 controls myeloid progenitor growth during emergency granulopoiesis.

Huiyuan Zhang, Hoainam Nguyen-Jackson, Athanasia D Panopoulos, Haiyan S Li, Peter J Murray, Stephanie S Watowich

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 225 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. ExploitingFrontiers in immunology · 2026
    Article
  7. Review
  8. Review
  9. A new STAT3-based potency assay for human G-CSF analog therapeutics.Journal of pharmaceutical and biomedical analysis · 2025
    Article
  10. Review
  11. TScience advances · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Huiyuan ZhangDepartment of Immunology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-1903, USA.
Hoainam Nguyen-Jackson
Athanasia D Panopoulos
Haiyan S Li
Peter J Murray
Stephanie S Watowich
The University of Texas MD Anderson Cancer Center · USSt. Jude Children's Research Hospital · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Training Program in Cancer ImmunobiologyT32CA009598 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ALLISON, JAMES P · 1988 to 2014
$4.9M
Cytokine Regulation of Dendritic Cell DevelopmentR21AI073587 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WATOWICH, STEPHANIE S · 2007 to 2008
$409k
NCI NIH HHS P30 CA016672NCI NIH HHS P30CA16672NCI NIH HHS T32 CA009598NCI NIH HHS T32-CA-09598-16NIAID NIH HHS AI073587NIAID NIH HHS R21 AI073587
6 · The paper itself

Abstract

Granulocyte colony-stimulating factor (G-CSF) mediates "emergency" granulopoiesis during infection, a process that is mimicked by clinical G-CSF use, yet we understand little about the intracellular signaling cascades that control demand-driven neutrophil production. Using a murine model with conditional deletion of signal transducer and activator of transcription 3 (STAT3) in bone marrow, we investigated the cellular and molecular mechanisms of STAT3 function in the emergency granulopoiesis response to G-CSF administration or infection with Listeria monocytogenes, a pathogen that is restrained by G-CSF signaling in vivo. Our results show that STAT3 deficiency renders hematopoietic progenitor cells and myeloid precursors refractory to the growth-promoting functions of G-CSF or L monocytogenes infection. STAT3 is necessary for accelerating granulocyte cell-cycle progression and maturation in response to G-CSF. STAT3 directly controls G-CSF-dependent expression of CCAAT-enhancer-binding protein β (C/EBPβ), a crucial factor in the emergency granulopoiesis response. Moreover, STAT3 and C/EBPβ coregulate c-Myc through interactions with the c-myc promoter that control the duration of C/EBPα occupancy during demand-driven granulopoiesis. These results place STAT3 as an essential mediator of emergency granulopoiesis by its regulation of transcription factors that direct G-CSF-responsive myeloid progenitor expansion.

Indexed as

LeukopoiesisAnimalsCCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding ProteinsCell CycleGene Expression RegulationGranulocyte Colony-Stimulating FactorGranulocytesHematopoietic Stem CellsListeria monocytogenesMicePromoter Regions, GeneticProto-Oncogene Proteins c-mycSignal TransductionSTAT3 Transcription FactorCCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding ProteinsCEBPA protein, mouseCebpb protein, mouseGranulocyte Colony-Stimulating FactorProto-Oncogene Proteins c-mycSTAT3 Transcription Factor

Identifiers

PMID20581311
PMCPMC2953883
OpenAlexW2041168245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.